Enrico Munari
Enrico Munari
Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy
Email verificata su unibs.it
Titolo
Citata da
Citata da
Anno
TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urine
I Kinde, E Munari, SF Faraj, RH Hruban, M Schoenberg, T Bivalacqua, ...
Cancer research 73 (24), 7162-7167, 2013
2182013
18F-DCFBC PET/CT for PSMA-based detection and characterization of primary prostate cancer
SP Rowe, KL Gage, SF Faraj, KJ Macura, TC Cornish, ...
Journal of Nuclear Medicine 56 (7), 1003-1010, 2015
1852015
Human NK cells: surface receptors, inhibitory checkpoints, and translational applications
S Sivori, P Vacca, G Del Zotto, E Munari, MC Mingari, L Moretta
Cellular & molecular immunology 16 (5), 430-441, 2019
1442019
Killer Ig-like receptors (KIRs): their role in NK cell modulation and developments leading to their clinical exploitation
D Pende, M Falco, M Vitale, C Cantoni, C Vitale, E Munari, A Bertaina, ...
Frontiers in immunology 10, 1179, 2019
1112019
Assessment of tumoral PD-L1 expression and intratumoral CD8+ T cells in urothelial carcinoma
SF Faraj, E Munari, G Guner, J Taube, R Anders, J Hicks, A Meeker, ...
Urology 85 (3), 703. e1-703. e6, 2015
1102015
Differential expression of cathepsin K in neoplasms harboring TFE3 gene fusions
G Martignoni, S Gobbo, P Camparo, M Brunelli, E Munari, D Segala, ...
Modern Pathology 24 (10), 1313-1319, 2011
1032011
PD-L1 expression heterogeneity in non–small cell lung cancer: defining criteria for harmonization between biopsy specimens and whole sections
E Munari, G Zamboni, G Lunardi, L Marchionni, M Marconi, M Sommaggio, ...
Journal of Thoracic Oncology 13 (8), 1113-1120, 2018
1012018
PD-L1 expression heterogeneity in non-small cell lung cancer: evaluation of small biopsies reliability
E Munari, G Zamboni, M Marconi, M Sommaggio, M Brunelli, G Martignoni, ...
Oncotarget 8 (52), 90123, 2017
772017
“Interchangeability” of PD-L1 immunohistochemistry assays: a meta-analysis of diagnostic accuracy
E Torlakovic, HJ Lim, J Adam, P Barnes, G Bigras, AWH Chan, ...
Modern Pathology 33 (1), 4-17, 2020
732020
Clear cell papillary renal cell carcinoma: micro-RNA expression profiling and comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma
E Munari, L Marchionni, A Chitre, M Hayashi, G Martignoni, M Brunelli, ...
Human pathology 45 (6), 1130-1138, 2014
692014
Clear cell papillary renal cell carcinoma: micro-RNA expression profiling and comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma
E Munari, L Marchionni, A Chitre, M Hayashi, G Martignoni, M Brunelli, ...
Human pathology 45 (6), 1130-1138, 2014
692014
PD-L1 assays 22C3 and SP263 are not interchangeable in non–small cell lung cancer when considering clinically relevant cutoffs
E Munari, G Rossi, G Zamboni, G Lunardi, M Marconi, M Sommaggio, ...
The American journal of surgical pathology 42 (10), 1384-1389, 2018
602018
High frequency of TERT promoter mutation in small cell carcinoma of bladder, but not in small cell carcinoma of other origins
X Zheng, J Zhuge, SM Bezerra, SF Faraj, E Munari, JT Fallon, XJ Yang, ...
Journal of hematology & oncology 7 (1), 1-5, 2014
592014
Neuroendocrine differentiation in breast carcinoma: clinicopathological features and outcome
G Bogina, E Munari, M Brunelli, L Bortesi, M Marconi, M Sommaggio, ...
Histopathology 68 (3), 422-432, 2016
562016
Group 3 innate lymphoid cells regulate neutrophil migration and function in human decidua
D Croxatto, A Micheletti, E Montaldo, P Orecchia, F Loiacono, ...
Mucosal immunology 9 (6), 1372-1383, 2016
552016
PD-1 in human NK cells: evidence of cytoplasmic mRNA and protein expression
FR Mariotti, S Petrini, T Ingegnere, N Tumino, F Besi, F Scordamaglia, ...
Oncoimmunology 8 (3), 1557030, 2019
512019
Magnitude of PD-1, PD-L1 and T lymphocyte expression on tissue from castration-resistant prostate adenocarcinoma: an exploratory analysis
F Massari, C Ciccarese, A Calio, E Munari, L Cima, AB Porcaro, G Novella, ...
Targeted oncology 11 (3), 345-351, 2016
512016
Identification and validation of protein biomarkers of response to neoadjuvant platinum chemotherapy in muscle invasive urothelial carcinoma
AS Baras, N Gandhi, E Munari, S Faraj, L Shultz, L Marchionni, ...
PloS one 10 (7), e0131245, 2015
482015
Gemcitabine and cisplatin neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma: Predicting response and assessing outcomes
NM Gandhi, A Baras, E Munari, S Faraj, LO Reis, JJ Liu, M Kates, ...
Urologic Oncology: Seminars and Original Investigations 33 (5), 204. e1-204. e7, 2015
442015
Presence of innate lymphoid cells in pleural effusions of primary and metastatic tumors: Functional analysis and expression of PD‐1 receptor
N Tumino, S Martini, E Munari, F Scordamaglia, F Besi, FR Mariotti, ...
International journal of cancer 145 (6), 1660-1668, 2019
422019
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20